CDKN1C and ovarian carcinoma: Expression of two cyclin-dependent kinase (CDK) inhibitors CDKN1A/p21 and CDKN1C/p57 were also demonstrated to be regulated by EZH2 in cervical and ovarian cancer, respectively (12,13).